PURLs

It’s Time to Reconsider Early-morning Testosterone Tests

Author and Disclosure Information

 

CHALLENGES TO IMPLEMENTATION
Your lab’s policies might require early-morning draws
There will probably be few barriers to implementing this change, unless local laboratory policies are inflexible regarding the timing of testosterone draws.

REFERENCES
1. Welliver RC Jr, Wiser HJ, Brannigan RE, et al. Validity of midday total testosterone levels in older men with erectile dysfunction. J Urol. 2014;192:165-169.
2. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.
3. Cooke RR, McIntosh JE, McIntosh RP. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin Endocrinol (Oxf). 1993;39:163-171.
4. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56:1278-1281.
5. Brambilla DJ, Matsumoto AM, Araujo AB, et al. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94:907-913.
6. Crawford ED, Barqawi AB, O’Donnell C, et al. The association of time of day and serum testosterone concentration in a large screening population. BJU Int. 2007;100:509-513.

ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Copyright © 2015. The Family Physicians Inquiries Network. All rights reserved.

Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice. 2015;64(7):418-419.

Pages

Recommended Reading

Angina Drug Ranolazine Lowers Glucose in Type 2 Diabetes
Clinician Reviews
Poor Glucose Control Linked With Longer Hospital Stay, Higher Costs
Clinician Reviews
New Guidelines Focus on Pediatric Thyroid Nodules and Cancer
Clinician Reviews
VIDEO: Dementia Rate Doubled in Type 1 Diabetics
Clinician Reviews
Be Sure to Look for Secondary Diabetes
Clinician Reviews
Insulin Resistance Linked to Decreased Brain Metabolism, Memory Function
Clinician Reviews
Poor Glycemic Control Upped Chances of Coronary Events After CABG
Clinician Reviews
A Call to Action on Metabolic Syndrome and Pediatric Psoriasis
Clinician Reviews
Estrogen Therapy Linked to Brain Atrophy in Women With Diabetes
Clinician Reviews
Lifestyle Changes, Surgical Weight Loss Benefit NAFLD
Clinician Reviews

Related Articles